Cytogenetic classification.
| . | SWOG Criteria27 . | MRC criteria2: As for SWOG, except: - . |
|---|---|---|
| Abbreviations: SWOG, Southwestern Oncology Group; MRC, Medical Research Council; abn, abnormalities of | ||
| Favorable | t(15;17) – with any other abnormality | |
| inv(16)/t(16;16)/del(16q) – with any other abnormality | ||
| t(8;21) – without del(9q) or complex karyotype | t(8;21) – with any other abnormality | |
| Intermediate | +8, -Y, +6, del(12p) | abn 11q23 |
| normal karyotype | del(9q), del(7q) – without other abnormalities | |
| Complex karyotypes (≥ 3 abnormalities, but < 5 abnormalities) | ||
| All abnormalities of unknown prognostic significance | ||
| Unfavorable | -5/del(5q), -7/del(7q), | |
| t(8;21) with del(9q) or complex karyotype | ||
| inv(3q), abn 11q23, 20q, | ||
| 21q, del(9q), t(6;9) | ||
| t(9;22), abn 17p, | ||
| Complex karyotypes (≥ 3 abnormalities) | Complex karyotypes (≥ 5 abnormalities) | |
| Unknown | All other clonal chromosomal aberrations with fewer than 3 abnormalities | |
| . | SWOG Criteria27 . | MRC criteria2: As for SWOG, except: - . |
|---|---|---|
| Abbreviations: SWOG, Southwestern Oncology Group; MRC, Medical Research Council; abn, abnormalities of | ||
| Favorable | t(15;17) – with any other abnormality | |
| inv(16)/t(16;16)/del(16q) – with any other abnormality | ||
| t(8;21) – without del(9q) or complex karyotype | t(8;21) – with any other abnormality | |
| Intermediate | +8, -Y, +6, del(12p) | abn 11q23 |
| normal karyotype | del(9q), del(7q) – without other abnormalities | |
| Complex karyotypes (≥ 3 abnormalities, but < 5 abnormalities) | ||
| All abnormalities of unknown prognostic significance | ||
| Unfavorable | -5/del(5q), -7/del(7q), | |
| t(8;21) with del(9q) or complex karyotype | ||
| inv(3q), abn 11q23, 20q, | ||
| 21q, del(9q), t(6;9) | ||
| t(9;22), abn 17p, | ||
| Complex karyotypes (≥ 3 abnormalities) | Complex karyotypes (≥ 5 abnormalities) | |
| Unknown | All other clonal chromosomal aberrations with fewer than 3 abnormalities | |